
This episode discusses the surge in demand for menopausal hormone therapies following the FDA's regulatory changes and the associated concerns.
About this episode: Following the FDA's removal of black box warnings for hormone therapy drugs, demand has skyrocketed for menopause treatments. In this episode: why this explosion in popularity marks a trend in the right direction for quality reproductive care while also raising concerns about "menowashed" products and blanket prescribing of hormonal interventions. Guests: Dr. Wendy L. Bennett , MPH, is a primary care doctor and associate professor with appointments at the Johns Hopkins Bloomberg School of Public Health and School of Medicine. Dr. Tina Zhang is a primary care doctor and assistant professor at the Johns Hopkins University School of Medicine. Host: Stephanie Desmon, MA, is a former journalist, author, and the director of public relations and communications for the Johns Hopkins Center for Communication Programs . Show links and related content: Why the 'mad scramble' to fill hormone therapy prescriptions for menopause —NPR FACT SHEET: FDA Initiates Removal of "Black Box" Warnings from Menopausal Hormone Replacement Therapy Products —U.S. Department of Health and Human Services What Is a Black Box Warning? —Johns Hopkins Bloomberg School of Public Health…
Explore listener stats, chart rankings, contacts and more on the Public Health On Call podcast page.